Home > Cashflow Statement > MANKIND PHARMA

MANKIND PHARMA
Cashflow Statement

MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax₹1,671 Cr₹1,975 Cr₹1,692 Cr₹1,438 Cr₹865 Cr
Adjustment ₹298 Cr₹31 Cr₹-5.66 Cr₹105 Cr₹87 Cr
Changes In working Capital ₹167 Cr₹-586 Cr₹-95 Cr₹-140 Cr₹-9.74 Cr
Cash Flow after changes in Working Capital ₹2,136 Cr₹1,419 Cr₹1,591 Cr₹1,403 Cr₹942 Cr
Cash Flow from Operating Activities ₹1,813 Cr₹920 Cr₹1,137 Cr₹1,072 Cr₹600 Cr
Cash Flow from Investing Activities ₹-1,054 Cr₹-1,369 Cr₹-1,222 Cr₹-439 Cr₹-444 Cr
Cash Flow from Financing Activities ₹-740 Cr₹605 Cr₹-7.81 Cr₹-527 Cr₹-175 Cr
Net Cash Inflow / Outflow ₹19 Cr₹155 Cr₹-93 Cr₹106 Cr₹-19 Cr
Opening Cash & Cash Equivalents ₹283 Cr₹127 Cr₹220 Cr₹116 Cr₹136 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹2.32 Cr₹0.48 Cr₹0.38 Cr₹3.60 Cr₹-0.02 Cr
Closing Cash & Cash Equivalent ₹305 Cr₹283 Cr₹127 Cr₹226 Cr₹116 Cr

Compare Cashflow Statement of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹87,330.8 Cr -6.6% -6.6% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹365,071.0 Cr 0.2% -6.1% 55.7% Stock Analytics
CIPLA ₹111,808.0 Cr -2.5% -5.1% 48.6% Stock Analytics
DIVIS LABORATORIES ₹104,300.0 Cr -0.9% 5% 19.2% Stock Analytics
ZYDUS LIFESCIENCES ₹101,202.0 Cr 1.8% 2.2% 88.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,035.0 Cr -3.7% -1.4% 26% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-6.6%

-6.6%

NA
SENSEX

-1.4%

-0.6%

20.1%


You may also like the below Video Courses